Government ❯ Politics ❯ Health Policy

Abortion

Mifepristone Medication Abortion Nomination Process Pro-Life Movement Mifepristone Approval Confirmation Hearings Mifepristone Regulation Pro-Life Advocacy Vaccine Mandates EMTALA Mifepristone Safety Research Studies Drug Approval Legislation Medication Safety Conscientious Objection Conscience Objection Gender Identity Fetal Tissue Research Emergency Medical Treatment Robert F. Kennedy Jr. Pro-Choice Stance Controversial Figures Abortion Rights

HHS Bars Fetal Tissue From Elective Abortions in Federally Funded Research

The policy shifts federal research away from primary fetal tissue toward alternative models with exemptions for established cell lines.

Live Action Urges HHS and FDA to Suspend Mifepristone After Undercover Planned Parenthood Calls

Republicans Press Trump Administration to Halt Mail-Order Abortion Pills Crossing State Lines

Republicans Push to Restore In‑Person Rules for Abortion Pill at Fiery Senate Hearing

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

Senate Democrats Press FDA on Mifepristone Review After Court Strikes Down Restrictions

GOP Senators Press FDA Over Generic Abortion Pill Approval